Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Instil Bio, Inc. chart...

About the Company

We do not have any company description for Instil Bio, Inc. at the moment.

Exchange

Nasdaq

$14M

Total Revenue

335

Employees

$70M

Market Capitalization

-1.14

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TIL News

Instil Bio (TIL) Price Target Decreased by 23.15% to 28.22

6d ago, source: Fintel on MSN

The average one-year price target for Instil Bio (NasdaqCM:TIL) has been revised to 28.22 / share. This is an decrease of ...

Instil Bio Inc TIL

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

1mon ago, source: Business Insider

DALLAS, March 21, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies ...

Instil Bio Stock (NASDAQ:TIL), Quotes and News Summary

1mon ago, source: Benzinga.com

Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent ...

Instil Bio Announces Voluntary Pause of Enrollment in Ongoing Clinical Trials Related to Manufacturing

1mon ago, source: ADVFN

Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with ...

Instil Bio, Inc. Common Stock (TIL)

1d ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Instil Bio Inc TIL

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Instil Bio Inc

29d ago, source: U.S. News & World Report

Are Financial Advisors Worth It? Beyond stock picking, today's advisors help clients plan for a wide range of financial and life goals.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...